2007-August Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Wed Aug 1 15:22:01 2007
Ending: Fri Aug 31 15:14:05 2007
Messages: 113

• [Ip-health] AIDES and Act Up-Paris call for clarification of the EC's position regarding compulsory licensing in Thailand   =?windows-1252?Q?J=E9r=F4me_Martin?=
• [Ip-health] KEI Statement on the Novartis Lawsuit in India   Malini Aisola
• [Ip-health] EU Opposes Cheap Medicines for AIDS in Thailand X-MIMETrack: Itemize by SMTP Server on DOMBRU02/BRU/S/MSF(Release 6.5.5|November 30, 2005) at 30/08/2007 11:33:08, Serialize by Router on DOMBRU02/BRU/S/MSF(Release 6.5.5|November 30, 2005) at 30/08/2007 11:33:25, Serialize complete at 30/08/2007 11:33:25   Alexandra.HEUMBER@brussels.msf.org
• [Ip-health] I-MAK Challenges Patents on Lifesaving HIV Drug Combination in Europe, India   Tahir Amin
• [Ip-health] I-MAK Challenges Patents on Lifesaving HIV Drug Combination in Europe, India   Tahir Amin
• [Ip-health] Novartis Press Release on its defeat in India Lies Again   B.Baker@neu.edu
• [Ip-health] E.U. Demands on Thailand are based on Lies and Misrepresentations   B.Baker@neu.edu
• [Ip-health] New taxes on medicines set to hit hard on poor   Dean Baker
• [Ip-health] Novartis press release: Novartis concerned Indian court ruling will discourage investments in innovation needed to bring better medicines to patients   Thiru Balasubramaniam
• [Ip-health] Extracts of WTO member comments on the Trade Policy Review of India   Thiru Balasubramaniam
• [Ip-health] New York Times: Setback for Novartis in India Over Drug Patent   Thiru Balasubramaniam
• [Ip-health] Extract of comments by the United States at the WTO Trade Policy Review (on India)   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Novartis Case Furthers India Patent Debate   Thiru Balasubramaniam
• [Ip-health] New York Times: More Generics Slow the Surge in Drug Prices   Thiru Balasubramaniam
• [Ip-health] WHO guide on compulsory licensing and government use: Forthcoming?   Thiru Balasubramaniam
• [Ip-health] Financial Times: Novartis fails in Indian legal challenge   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Red Cross Is Sued by J&J Over Signature Emblem   Thiru Balasubramaniam
• [Ip-health] WIPO indicative draft outline: Survey of International Patent Issues   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal editorial: Drug Patents in India   Thiru Balasubramaniam
• [Ip-health] Brian Druker (Glivec scientist): Don't abuse patents: scientists   Thiru Balasubramaniam
• [Ip-health] Novartis verdict   Jean Blaylock
• [Ip-health] Novartis press release   Jean Blaylock
• [Ip-health] Oxfam / CARE / EAA press release on Novartis   Jean Blaylock
• [Ip-health] Churches press release on Novartis   Jean Blaylock
• [Ip-health] Novartis to divert India investment after patent case   Jean Blaylock
• [Ip-health] Novartis drops AIDS drug plea   Jean Blaylock
• [Ip-health] The Economist: The poor world is getting the rich world's diseases   Rosa Castro
• [Ip-health] Note of the GTPI/Rebrip on Novartis' defeat in India's High Court   Gabriela Costa Chaves
• [Ip-health] UK:NHS drug costs to be renegotiated   Michelle Childs
• [Ip-health] EU Commission issues 2 consultations on pharmaceuticals   Michelle Childs
• [Ip-health] BBC E-mail: WHO warns of global epidemic risk   Michelle Childs
• [Ip-health] Re: Ip-health digest, Vol 1 #2413 - 6 msgs   Carlos M Correa
• [Ip-health] Novartis loses fight for cancer drug patent   Gopal Dabade
• [Ip-health] Novartis in India   Gopal Dabade
• [Ip-health] The cost of the newest cancer drugs   Dr Dirk Van Duppen
• [Ip-health] USTR Korea Asia resigns   Sean Flynn
• [Ip-health] New taxes on medicines set to hit hard on poor   Alec van Gelder
• [Ip-health] Schedule of IGWG Consultations   Spring Gombe
• [Ip-health] Oxfam- MSF Joint letter to Commissioner Mandelson on Thailand CL issue   Alexandra HEUMBER
• [Ip-health] BIO's play for perpetual monopoly [Deciding Newness of Biologics as a Basis for Exclusivity]   Biotech. Info. Inst.
• [Ip-health] Re: [Commons-Law] Text of Madras High Court judgment   Prashant Iyengar
• [Ip-health] Text of Madras High Court judgment   Julie
• [Ip-health] Big Pharma’s insatiable greed for profit: The case of Thailand and India   Kannikar KIJTIWATCHAKUL
• [Ip-health] US ambassador's letter to Thai prime Minister on CLs   Kannikar KIJTIWATCHAKUL
• [Ip-health] Thai civil society joins forces with international NGOs to denounce the EU Trade Commissioner and the US Ambassador for their interference in Thailand’s CL decision   Kannikar KIJTIWATCHAKUL
• [Ip-health] US ambassador's letter to Thai prime Minister on CLs   Kannikar KIJTIWATCHAKUL
• [Ip-health] AHF Campaign Challenges Cipla Over Drug Pricing in India:"Profit at What Cost? AIDS Drugs for All" -- New Delhi Press Conf Thurs Aug 9 @3pm   Ged Kenslea
• [Ip-health] TACD IP Expert Vacancy   Julian Knott
• [Ip-health] SAVE THE DATE: TACD Conference "The reform of WIPO: Implementing the Development Agenda" - Sept 17 Geneva   Julian Knott
• [Ip-health] SpicyIP: The Novartis Dispute   Mrinalini Kochupillai
• [Ip-health] US attorney target after refusing to slow down prosecution of drug company   Gaelle Krikorian
• [Ip-health] Abbott tampering with safety concerns on wikipedia   Gaelle Krikorian
• [Ip-health] Swiss govt not to take Novartis case to WTO   Gopa Kumar
• [Ip-health] US consultation on IGWG - 17 hours notice.   James Love
• [Ip-health] The US has cancelled today's IGWG consultation, and will reschedule for a later date   James Love
• [Ip-health] Job Posting: Medical Director, MSF Access to Essential Medicines Campaign - deadline Sept 15   Anne St. Martin
• [Ip-health] IP Watch: WHO Draft Negotiating Text On IP Cautiously Received   Alicia Martin-Santos
• [Ip-health] =?iso-8859-1?q?IP=20WATCH:=20Rejected=20Novartis=20Cases=20Leave=20India?= =?iso-8859-1?q?=92s=20TRIPS=20Compliance=20Unchallenged?=   Alicia Martin-Santos
• [Ip-health] (full text) More medicines for neglected and emerging infectious diseases   Suerie Moon
• [Ip-health] Thoughts in Colours Blog: Of Trivialities and Falling Skies: A Look at the Decision in the Novartis Case in India   Sisule Musungu
• [Ip-health] BIO v. DC and the New Need to Eliminate Federal Patent Law Preemption of State and Local Price and Product Regulation   Mike Palmedo
• [Ip-health] House passes farm appropriations bill w/ amendment to legalize drug reimportation   Mike Palmedo
• [Ip-health] New taxes on medicines set to hit hard on poor   Mike Palmedo
• [Ip-health] IFPMA: =?windows-1252?Q?India=92s_Innovative_Potential_Con?= =?windows-1252?Q?tinues_to_be_Stifled_by_Its_Poor_Patent_?= =?windows-1252?Q?Law?=   Mike Palmedo
• [Ip-health] Doug Bandow Op-ed: Stealing Drugs, Hurting Poor   Mike Palmedo
• [Ip-health] House provision in agriculture bill which prohibits the FDA from blocking parallel trade in pharmaceuticals   Mike Palmedo
• [Ip-health] WSJ op-ed on how compulsory licenses are really just for emergencies   Mike Palmedo
• [Ip-health] Bill Richardson on trade and access to medicines   Mike Palmedo
• [Ip-health] Indian court rejects Novartis patent challenge   Prabhu Ram
• [Ip-health] India may patent small changes   Prabhu Ram
• [Ip-health] =?WINDOWS-1252?Q?Proceedings_on_Novartis=92_appeal_before_IPAB_stayed?=   Prabhu Ram
• [Ip-health] Novartis: do Indian patent laws stifle research?   Prabhu Ram
• [Ip-health] Novartis case may not reach WTO!   Hafiz Aziz-ur- Rehman
• [Ip-health] Taking on Big Pharma over HIV,   Matthew Rimmer
• [Ip-health] Joint Standing Committee on Treaties in the Australian Parliament holds Public Hearing on the Hong Kong Amendment to the TRIPS Agreement:   Matthew Rimmer
• [Ip-health] Joint Standing Committee report on Hong Kong Amendment to the TRIPS Agreement   Matthew Rimmer
• [Ip-health] Thais warned by Eur Com on drug pricing pressure   Sarah Rimmington
• [Ip-health] Pharmalot: Response from Eli Lilly to Pharma Disclose Campaign   Sarah Rimmington
• [Ip-health] Big Pharma hits back at Indian patent laws   Sarah Rimmington
• [Ip-health] Bayer spent more than $2m on lobbying USG in first half of 2007   Sarah Rimmington
• [Ip-health] Please endorse U.S. Cong. sign-on letter regarding access to medicines   Sarah Rimmington
• [Ip-health] Indian ministries move to include data protection clause in pharma law   Sarah Rimmington
• [Ip-health] =?windows-1252?Q?Liberation=3A_Le_Kenya_propose_un_fon?= =?windows-1252?Q?ds_mondial_pour_faciliter_l=92acc=E8s_des_p?= =?windows-1252?Q?ays_pauvres_aux_m=E9dicaments=2E?=   Judit Rius Sanjuan
• [Ip-health] Patent System's Revamp Hits Wall   Judit Rius Sanjuan
• [Ip-health] World Bank: Legal Aspects of HIV/AIDS. A Guide for Policy and Law Reform   Judit Rius Sanjuan
• [Ip-health] VACANCY: Senior Communication and Press Officer at DNDi, Geneva   Ann-Marie Sevcsik
• [Ip-health] Reposting the Senior Communications & Press Officer Position at DNDi   Ann-Marie Sevcsik
• [Ip-health] TPA and Public Health   Dalindyebo Bafana Shabalala
• [Ip-health] IP Quarterly 2nd Quarter 2007   Dalindyebo Bafana Shabalala
• [Ip-health] Pipeline patents   Ken Shadlen
• [Ip-health] MSF Statement on Novartis Court Ruling in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Times of India: Indian Patent Act a role model   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] New taxes on medicines set to hit hard on poor   Riaz K. Tayob
• [Ip-health] New taxes on medicines set to hit hard on poor   Riaz K. Tayob
• [Ip-health] New taxes on medicines set to hit hard on poor   Riaz K. Tayob
• [Ip-health] New book on neoliberalism and health (One Chapter Courtesy Lancet)   Riaz K. Tayob
• [Ip-health] COLOMBIAN AIDS ACTIVISTS MEET TO CALL FOR REMOVAL OF BARRIERS TO ACCESS TO GENERIC DRUGS FOR HIV/AIDS PATIENTS IN COLOMBIAN FREE TRADE PROMOTION AGREEMENT   Clinton Trout
• [Ip-health] Unsafe At The FDA   Jeff Williams
• [Ip-health] Text of Madras High Court judgment   Jeff Williams
• [Ip-health] Indian Patent law victory - A Note of Thanks   aidslaw
• [Ip-health] Email alert: August issue of the WHO Bulletin   bulletin
• [Ip-health] Save the Date! Lessons from NAFTA Conference, Oct. 22-23   elisabeth@tradejusticecampaign.org
• [Ip-health] Oxford University Press: Human Rights and the WTO. The Case of Patents and Access to Medicines   hhesterm@mpil.de
• [Ip-health] ET: Novartis Not to Plead Novartis Case (misleading headline)   chan park
• [Ip-health] MADRAS HIGH COURT DISMISSES NOVARTIS' CHALLENGE TO THE INDIAN PATENT LAW   chan park
• [Ip-health] Reuters: Chennai court rejects Novartis patent challenge   chan park
• [Ip-health] Joint Statement by CPAA, MSF, DNP+ and Lawyers Collective on Novartis Judgment   chan park
• [Ip-health] Synopsis of Novartis Judgment   chan park
• [Ip-health] CARE, UNAIDS and Lawyers Collective HIV/AIDS Unit at ICAAP 8   chan park
• [Ip-health] IFPMA =?iso-8859-1?Q?Won=92t_Support_Global_Disclosure_of_Industry_Charitable_&?= Educational Donations]   srimmington@essentialinformation.org
• [Ip-health] Jean-Pierre Garnier of GlaxoSmithKline defends the pharmaceutical industry as he overhauls his own drugs firm   robert weissman
• [Ip-health] FDR on compulsory licensing and patent pools   robert weissman
• [Ip-health] UNAIDS Asia/Pacific: Other countries should follow the Thailand example   robert weissman

Last message date: Fri Aug 31 15:14:05 2007
Archived on: Fri Aug 31 14:14:05 2007

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...